default author photo

Sanjay V. Patel

Mayo Clinic

200 First Street SW

Rochester, MN 55905

United States

SCHOLARLY PAPERS

1

DOWNLOADS

43

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Dose delays and treatment interruptions secondary to ocular toxicity from BMCA-directed antibody drug conjugate therapy in relapsed multiple myeloma

Number of pages: 22 Posted: 27 Aug 2025 Last Revised: 07 Feb 2026
Matthew James Rees, Timothy T. Xu, Suheil Albert Atallah-Yunes, Kenneth J. C. Lim, Sikander Ailawadhi, Ricardo Parrondo, Rafael Fonseca, Peter Bergsagel, Suzanne Hayman, Angela Dispenzieri, Francis K. Buadi, David Dingli, Rahma Warsame, Prashant Kapoor, Jithma P. Abeykoon, Morie A. Gertz, Eli Muchtar, Taxiarchis V. Kourelis, Wilson I. Gonsalves, Vincet Rajkumar, Sanjay V. Patel and Shaji K. Kumar
affiliation not provided to SSRN, Mayo Clinic, Mayo Clinic, Mayo Clinic, affiliation not provided to SSRN, affiliation not provided to SSRN, Mayo Clinic, New York University (NYU) - Grossman School of Medicine, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic and Mayo Clinic - Division of Hematology
Downloads 43 (1,145,425)

Abstract:

Loading...

B-cell maturation antigen, antibody drug conjugates, Multiple myeloma, monoclonal gammopathy, keratopathy, adverse effects